It's quite obvious that petrozene is not performing as expected in the market, whether it be the industry's conservative nature, or the functionality of the fsnr product..one would think that if the product was as impressive as the last pr touted, then a new filing would have been presented by now..however, with the overwhelming silence from the company and the industry about petrozene, and the fact(as mentioned) that dynamis didn't exercise their warrants.it is evident that fsnr is at an impasse and quite possibly the end of the journey?
News 
Market Data 
Discover 
